Archive - Page 2
European Migraine Patients' Call to Action
Migraine patient organizations across Europe have issued a Call to Action to improve the quality of lives of migraineurs. » read more
Headache, Sleep Problems Connected in Children: Mayo Clinic Report
Mayo Clinic researchers have found that frequent headaches in children appear to be associated with sleep problems. More than two-thirds of children studied who suffer from chronic daily headache also experience sleep disturbance, especially delay in sleep onset. For children with episodic headaches, one-fifth had sleep problems. The findings will be presented this week at the 24th Annual Conference on Sleep Disorders in Infancy and Childhood in Rancho Mirage, Calif. » read more
Life and Migraine - Documentary about Life with Chronic Migraine
Life and Migraine is a U.S.-based documentary about the lives of 13 people with chronic headaches. It is an engaging and very real look at how chronic headaches affect the lives of ordinary people. The stories, both emotional and informative, are punctuated with factual information about headaches, including the astounding fact that 29.5 million people in the U.S. have migraine and only half of them ar » read more
French Migraineurs Under-diagnosed and Under-treated
Only 20% of all migraine sufferers in France are medically followed for migraine, according to a study presented at the 9th Congress of the European Federation of Neurological Societies in Athens, Greece in September 2005. In nearly two-thirds of cases, migraine sufferers do not visit their doctor specifically for migraine, resulting in a large population of under-diagnosed and under-treated migraineurs. » read more
Topamax Effective Pediatric Migraine Preventive: Preliminary Results
A preliminary study suggests that topiramate (Topamax) may be an effective migraine preventive therapy in children. Topamax, an anticonvulsant, was initially developed to treat epileptic seizures. It was approved for migraine prevention in the U.S in 2004 for adults and is available in many countries worldwide. There are currently no migraine preventive therapies available for use in children. » read more
How to Develop a Headache Organization
Introduction Headache disorders affect men, women and children everywhere in the world. They are often disabling and burdensome. Developments in research in recent years have brought huge strides in the understanding of headache disorders and their management. But it may be many more years before "cures" emerge. In the meantime, people with headache disorders and their families and communities need support and practical help. Creating a headache organization is one » read more
Headaches Endure Over Time, Though Type Often Changes
Most children with headaches continue to have moderate or severe headaches as adults, according to a study, published in the Archives of Pediatric Adolescent Medicine. » read more
What do you do to help get people off useless medications?
Dr. John Claude Krusz received his Ph.D. in neuropharmacology from State University of New York, Downstate Medical Center in 1975 and his Medical Degree from State University of New York at Buffalo School of Medicine in 1983. He is a Diplomate of the American Board of Neurology and Psychiatry and also the American Board of Forensic Examiners. He is board certified in Pain Management, EEG and Quantitative Electroencephalography. He is the Vice President of the American Board of Electroencephalogr » read more
Educated, Younger Patients Less Reliant on Doctors for Information
More than half of patients surveyed say they prefer to leave decisions about their medical care up to their doctor, according to a study published in The Journal of Family Practice. » read more
Most Topamax AEs Occur During Dosing Period, Not Maintenance
Topiramate (Topamax) is considered by experts to be an effective and generally well-tolerated migraine preventive therapy, as demonstrated in several large trials. The target dose for most migraine patients is 100 mg/day. The most common adverse events associated with Topamax are paresthesia (burning or prickling sensation that is usually felt in the hands, arms, legs, or feet), impairment in mental functioning, fatigue, weight loss, and nausea. » read more